Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

Overview of attention for article published in Nature Genetics, June 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 13 X posts from 11 X users, with an upper bound of 214,638 followers.

@smitha42 @tardistraveller @SKamath_MD @aakonc @pashtoonkasi @CathyEngMD @agrothey @DrEstfan @marklewismd @skopetz We have a new patient in @colontown with a MKRN1-BRAF fusion. Anyone come across this one? Would targeted therapy against BRAFV600E work in

PL: Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma http://t.co/y1288GgfbB #emblcangen

Recurrent NTRK2 and FGFR1 kinase alterations may open up therapeutic avenues for pilocytic astrocytomas - http://t.co/0vJZajyX4U

Why is the most common child brain tumour benign? @DKFZ and EMBL scientists may have an answer: http://t.co/GYmUScY7Jl @NatureGenetics

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.